๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Effect of baclofen on tardive dyskinesia

โœ Scribed by J. Gerlach; T. Rye; P. Kristjansen


Publisher
Springer
Year
1978
Tongue
English
Weight
588 KB
Volume
56
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Serotonin precursor effects in tardive d
โœ Henry A. Nasrallah; Robert E. Smith; Frederick J. Dunner; Mona McCalley-Whitters ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› Springer ๐ŸŒ English โš– 208 KB

In an attempt to determine the role of serotoninergic mechanisms in the pathophysiology of tardive dyskinesia, the serotonin precursor 5-hydroxytryptophan (5 HTP) with carbidopa, a peripheral decarboxylase inhibitor, were given in a double-blind crossover design to seven patients with longstanding t

Biphasic and long-lasting effect of ceru
โœ Tadashi Nishikawa; Masatoshi Tanaka; Itsuyuki Koga; Yasunori Uchida ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› Springer ๐ŸŒ English โš– 152 KB

A 55-year-old schizophrenic inpatient with buccolingual dyskinesia was treated with a single dose of ceruletide 0.8 gg/kg IM. Time-course effects of the drug were then followed for up to 6 weeks after injection. To assess changes in severity of bucco-lingual dyskinesia objectively, electromyogram (E

Effect of co-dergocrine mesylate on tard
โœ Jack Hajioff; Mackenzie Wallace ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› Springer ๐ŸŒ English โš– 265 KB

Twenty patients with signs of tardive dyskinesia secondary to antipsychotic medication participated in a double blind, controlled, parallel group study comparing codergocrine mesylate 4.5 mg once daily with a placebo. After 6 weeks medication a reduction in dyskinetic scores occurred in both groups,

Cholinergic suppression of tardive dyski
โœ W. E. Fann; C. R. Lake; C. J. Gerber; G. M. McKenzie ๐Ÿ“‚ Article ๐Ÿ“… 1974 ๐Ÿ› Springer ๐ŸŒ English โš– 408 KB

Tardive dyskinesia (TD), a hyperkinetic disorder associated with long-term neuroleptic treatment, may be a manifestation of imbalance of opposing DA and ACh dependent systems in the CNS (i.e., hyperdopamine activity or hypoeholinergic function). Dopamine blocking agents give some transient relief of